Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies

Peripheral T-cell lymphomas (PTCLS) comprise a diverse group of difficult to treat, very aggressive non-Hodgkin's lymphomas (NHLS) with poor prognoses and dismal patient outlook. Despite the fact that PTCLs comprise the majority of T-cell malignancies, the standard of care is poorly established...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Chen, Kevin H., Wada, Masayuki, Firor, Amelia E., Pinz, Kevin G., Jares, Alexander, Liu, Hua, Salman, Huda, Golightly, Marc, Lan, Fengshuo, Jiang, Xun, Ma, Yupo
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5302909/
https://ncbi.nlm.nih.gov/pubmed/27494836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars